Evox Therapeutics Competitors and Similar CompaniesClear all
Biocept's competitors and similar companies include Codiak Biosciences.
 Biocept Biocept employs cell separation technology to develop a class of diagnostic assays for the early detection and diagnosis of cancer. |  Codiak Biosciences Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics. | |
Founding Date | Founding Date 1993 | Founding Date 2015 |
Type | Type Public | Type Public |
Tags | ||
Locations | Locations San Diego, US HQ | Locations Cambridge, US HQ |
Employees | Employees 878% decrease | Employees 992% decrease |
Valuation ($) | Valuation ($) N/A | Valuation ($) 2.8 m |
Financial | ||
Revenue (est.) | Revenue (est.) $25.9m (FY, 2022) | Revenue (est.) $22.9m (FY, 2021) |
Net income | Net income ($32.1m) (FY, 2022) | Net income ($37.2m) (FY, 2021) |
Funding | ||
Total funding raised | Total funding raised $ 15.9m | Total funding raised $ 168.5m |
For sources of this data, please see the company profile
View Company Profiles
Codiak Biosciences
HQ
Cambridge, US
Employees
99↓ 2% decrease
Codiak Biosciences is a biopharmaceutical company focused on the development of exosome-based therapeutics.
View company